2 drug(s) with this reaction
10,027 total reports
Systemic Lupus Erythematosus has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 10,027 adverse event reports mention systemic lupus erythematosus in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with systemic lupus erythematosus, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have systemic lupus erythematosus listed in their FDA adverse event reports, sorted by report count:
In addition to systemic lupus erythematosus, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have systemic lupus erythematosus listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE.
There are a combined 10,027 reports of systemic lupus erythematosus across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.